This inventor holds 11 USPTO granted patents. Top assignee: Smithkline Corporation. Active years: 1976-1982.
Location History:
- Elkins Park, PA (US) (1976)
- Philadelphia, PA (US) (1976 - 1982)
Company Filing History:
Years Active: 1976-1982
Title: Innovations of Robert G Pendleton: Pioneering Work in Alpha-2 Antagonism
Introduction: Robert G Pendleton is a prominent inventor based in Philadelphia, PA. With an impressive portfolio consisting of 11 patents, he has made significant contributions to the field of pharmacology. His innovative methods have opened new avenues for medical treatments, particularly involving unique chemical compounds.
Latest Patents: Among Pendleton's notable inventions, his latest patents include a method for producing alpha-2 antagonism, which involves administering thiadiazolo- and oxadiazolotetrahydroisoquinoline compounds. Additionally, he has developed 1,2,3,4-tetrahydroisoquinoline compounds that feature 7- and/or 8-sulfur substituents, which serve as inhibitors of phenylethanolamine N-methyltransferase. These advancements demonstrate his commitment to enhancing medical therapies through innovative chemical approaches.
Career Highlights: Robert G Pendleton has made substantial strides during his tenure at the SmithKline Corporation, where he has cultivated an environment of innovation. His work not only emphasizes the application of chemistry in medicinal development but also reflects the critical role of patents in protecting groundbreaking ideas and inventions.
Collaborations: Throughout his career, Pendleton has partnered with esteemed colleagues, including William Edward Bondinell and Carl Kaiser. These collaborations have enriched his research endeavors and fostered an environment conducive to innovation. Together, they have tackled complex problems in the field of pharmacology, leading to noteworthy advancements and patents.
Conclusion: Robert G Pendleton exemplifies the spirit of innovation in the pharmaceutical industry. His 11 patents showcase a dedication to developing novel therapeutic methods through unique chemical compounds. Clearly, Pendleton's work at the SmithKline Corporation and his collaborative efforts with fellow scientists have established him as a remarkable inventor in the realm of medical research.